Written by The Pharmaceutical Cartridges Market is expanding as pharmaceutical manufacturers increasingly adopt cartridge-based systems for injectable drug delivery. The market was valued at USD 1.99 billion in 2025 and is projected to reach USD 4.44 billion by 2035, registering a CAGR of 8.40% during 2026–2035. Growing use of biologic therapies, self-administration devices, and ready-to-use cartridge formats is supporting market development.
Glass remains the leading material segment, accounting for approximately 67.8% of the market in 2025 due to its established use in insulin and biologic delivery systems. Engineering plastics such as COC and COP are gaining attention because of their break resistance, lightweight characteristics, and chemical properties. The engineering plastics segment is projected to grow at a 12.5% CAGR through 2035.
Reusable pen injectors represented the largest delivery-device compatibility segment in 2025, while wearable on-body delivery pumps are projected to record faster growth. Diabetes was the leading therapeutic area, supported by demand for insulin delivery systems, whereas oncology cartridge applications are expected to expand as certain therapies move toward subcutaneous administration. Pharmaceutical companies currently represent the largest end-user segment, while CMOs and CDMOs are experiencing rapid growth.
North America held approximately 40.9% of global market revenue in 2025, supported by pharmaceutical manufacturing and biologic fill-finish capacity. Asia-Pacific is expected to register the fastest regional growth, with a projected CAGR of 10.5% through 2035. Increasing demand for insulin delivery, biologic medicines, ready-to-use packaging, and advanced manufacturing technologies is expected to create further opportunities for the market.
Discover emerging opportunities with in-depth research reports:
Saudi Arabia Medical Devices Market Share
Saudi Arabia Medical Devices Market Trends